2,6-Dichloro-4-morpholin-4-YL-benzaldehyde → 6-[5-(4-Chloro-phenyl)-[1,3,4]oxadiazol-2-yl]-2-(2,6-dichloro-4-morpholin-4-yl-phenyl)-1H-benzoimidazole

HRID 1513237노트

반응식

HRID 1513237 반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:12][C:11]([C:13]3[CH:14]=[C:15]([NH2:20])[C:16]([NH2:19])=[CH:17][CH:18]=3)=[N:10][N:9]=2)=[CH:4][CH:3]=1.[Cl:21][C:22]1[CH:29]=[C:28]([N:30]2[CH2:35][CH2:34][O:33][CH2:32][CH2:31]2)[CH:27]=[C:26]([Cl:36])[C:23]=1[CH:24]=O>CS(C)=O>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[O:12][C:11]([C:13]3[CH:18]=[CH:17][C:16]4[N:19]=[C:24]([C:23]5[C:22]([Cl:21])=[CH:29][C:28]([N:30]6[CH2:31][CH2:32][O:33][CH2:34][CH2:35]6)=[CH:27][C:26]=5[Cl:36])[NH:20][C:15]=4[CH:14]=3)=[N:10][N:9]=2)=[CH:6][CH:7]=1

참가 물질

4

실험 절차

To a 50 ml rbf was added 0.2250 g (0.785 mmol) 4-[5-(4-Chloro-phenyl)-[1,3,4]oxadiazol-2-yl]benzene-1,2-diamine, 0.2041 g (0.785 mmol) of 2,6-Dichloro-4-morpholin-4-yl-benzaldehyde, and 5 mL of DMSO. To this dark brown solution was added 0.0190 g (0.118 mmol) of FeCl3. It was allowed to stir open to air for 18 h. The crude was then extracted with EtOAc, and the combined extracts were washed with water, brine and dried with Na2SO4. The volatiles were removed in vacuo and the concentrate was purified on silica gel (ACN/DCM, 1:9 to 10:0) to give the title compound. 1H NMR (400 MHz, DMSO-d6) δ ppm 3.30 (d, J=5.05 Hz, 4 H) 3.71-3.77 (m, 4 H) 7.17 (s, 2 H) 7.70-7.75 (m, 2 H) 7.90 (d, J=8.72 Hz, 1 H) 7.99-8.07 (m, 1 H) 8.19 (d, J=8.21 Hz, 2 H) 8.27 (br. s., 1 H) 8.47 (s, 1 H) 13.17 (d, J=8.97 Hz, 1H. MS (m/z) 528.0 M (+1), tR=1.41, Meth 10

후처리

  1. extractionThe crude was then extracted with EtOAc
  2. washthe combined extracts were washed with water, brine
  3. dry with materialdried with Na2SO4
  4. customThe volatiles were removed in vacuo
  5. customthe concentrate was purified on silica gel (ACN/DCM, 1:9 to 10:0)

출처 및 근거

ORD 기록
ord-52fab5bf56004a1586513fc5b54d2140
출처 데이터셋
uspto-grants-2012_07
특허 번호
US08217065B2

반응 노트

불러오는 중…